Cargando…
Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
The gut microbiota plays a pivotal role in the onset and development of diabetes and its complications. Trimethylamine N-oxide (TMAO), a gut microbiota-dependent metabolite of certain nutrients, is associated with type 2 diabetes and its complications. Diabetic kidney disease (DKD) is one of the mos...
Autores principales: | Fang, Qing, Zheng, Binjie, Liu, Na, Liu, Jinfeng, Liu, Wenhui, Huang, Xinyi, Zeng, Xiangchang, Chen, Lulu, Li, Zhenyu, Ouyang, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243655/ https://www.ncbi.nlm.nih.gov/pubmed/34220546 http://dx.doi.org/10.3389/fphys.2021.682482 |
Ejemplares similares
-
Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
por: Fang, Qing, et al.
Publicado: (2021) -
Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
por: Li, Xueling, et al.
Publicado: (2019) -
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
por: Zixin, Ye, et al.
Publicado: (2022) -
The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
por: Liu, Wenhui, et al.
Publicado: (2021) -
Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction
por: Guo, Fei, et al.
Publicado: (2020)